Chris Fair
CEOMale0.0Global Dominance: 0.00%
Chris Fair is the CEO of Kuros, a Medtech company known for its bone regeneration product, MagnetOs. Under his leadership, Kuros has seen substantial revenue growth and is optimistic about future sales, particularly with new partnerships and applications on the horizon.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
CEO Chris Fair emphasized that Medtronic is one of several important partners for Kuros.
Kuros Biosciences bieten einen riskanten, aber attraktiven Investment CaseNeue Zürcher Zeitung·
Switzerland· 2026-07-23
Switzerland· 2026-07-23
Chris Fair tempered expectations during the presentation of Kuros's annual results.
Börsenkommentar zu Nestlé, U-Blox, Tecan und KurosNeue Zürcher Zeitung·Switzerland· 2025-03-14
Switzerland· 2025-03-14
